Pramodini Medicare Limited (NSE:PRAMODINI)
India · Delayed Price · Currency is INR 118.00
-0.10 (-0.08%)
At close: Aug 21, 2026
Pramodini Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 622.88 | 382.38 | 352.3 | 305.81 | 250.75 |
Other Revenue | 0 | - | - | - | - |
| 622.88 | 382.38 | 352.3 | 305.81 | 250.75 | |
Revenue Growth | 62.90% | 8.54% | 15.20% | 21.96% | 35.10% |
Cost of Revenue | 264.66 | 130.8 | 149.7 | 119.04 | 96.9 |
Gross Profit | 358.21 | 251.58 | 202.59 | 186.77 | 153.85 |
Selling, General & Admin | 24.98 | 25.54 | 24.4 | 24.23 | 22.15 |
Other Operating Expenses | 24.2 | 16.38 | 22.85 | 12.83 | 9.42 |
Operating Expenses | 123.09 | 84.72 | 91.14 | 87.29 | 67.97 |
Operating Income | 235.13 | 166.85 | 111.45 | 99.48 | 85.88 |
Interest Expense | -11.36 | -11.43 | -16.18 | -20.66 | -18.05 |
Interest & Investment Income | 10.9 | 3.09 | 5.65 | 3.78 | 1.38 |
Earnings From Equity Investments | - | -1.12 | -2.08 | - | -0.05 |
Other Non Operating Income (Expenses) | -1.66 | -1 | -0.16 | -0.03 | -0.03 |
EBT Excluding Unusual Items | 233 | 156.39 | 98.68 | 82.57 | 69.14 |
Gain (Loss) on Sale of Assets | 0.01 | - | - | - | - |
Pretax Income | 233.01 | 156.39 | 98.68 | 82.57 | 69.14 |
Income Tax Expense | 59.24 | 46.11 | 29.38 | 22.21 | 20.2 |
Net Income | 173.77 | 110.28 | 69.3 | 60.36 | 48.94 |
Net Income to Common | 173.77 | 110.28 | 69.3 | 60.36 | 48.94 |
Net Income Growth | 57.58% | 59.13% | 14.81% | 23.34% | 95.82% |
Shares Outstanding (Basic) | 17 | 17 | 17 | 13 | 10 |
Shares Outstanding (Diluted) | 17 | 17 | 17 | 13 | 10 |
Shares Change | - | 0.53% | 31.01% | 27.41% | - |
EPS (Basic) | 10.41 | 6.61 | 4.17 | 4.76 | 4.92 |
EPS (Diluted) | 10.41 | 6.61 | 4.17 | 4.76 | 4.92 |
EPS Growth | 57.58% | 58.29% | -12.36% | -3.19% | 95.82% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -44.21 | 120.86 | 94.89 | -2.52 | -2.52 |
Free Cash Flow Per Share | -2.65 | 7.24 | 5.71 | -0.20 | -0.25 |
Gross Margin | 57.51% | 65.79% | 57.51% | 61.07% | 61.36% |
Operating Margin | 37.75% | 43.64% | 31.64% | 32.53% | 34.25% |
Profit Margin | 27.90% | 28.84% | 19.67% | 19.74% | 19.52% |
Free Cash Flow Margin | -7.10% | 31.61% | 26.93% | -0.82% | -1.00% |
EBITDA | 309.03 | 209.66 | 153.91 | 135.88 | 120.74 |
EBITDA Margin | 49.61% | 54.83% | 43.69% | 44.43% | 48.15% |
D&A For EBITDA | 73.9 | 42.81 | 42.46 | 36.39 | 34.86 |
EBIT | 235.13 | 166.85 | 111.45 | 99.48 | 85.88 |
EBIT Margin | 37.75% | 43.64% | 31.64% | 32.53% | 34.25% |
Effective Tax Rate | 25.42% | 29.49% | 29.77% | 26.90% | 29.22% |
Revenue as Reported | 633.79 | 385.46 | 357.94 | 309.59 | 252.14 |
Advertising Expenses | - | - | 0.01 | - | 0.05 |